Literature DB >> 12959384

Surgical management of adrenal gland tumors with and without associated tumor thrombi in dogs: 40 cases (1994-2001).

Andrew E Kyles1, Edward C Feldman, Hilde E V De Cock, Philip H Kass, Kyle G Mathews, Elizabeth M Hardie, Richard W Nelson, Janet E Ilkiw, Clare R Gregory.   

Abstract

OBJECTIVE: To compare pathologic findings and results of adrenalectomy for adrenal gland tumors in dogs with and without vena caval tumor thrombi.
DESIGN: Retrospective study. ANIMALS: 40 dogs with adrenal gland tumors. PROCEDURE: Medical records were examined. An exact logistic regression analysis was used to evaluate associations between tumor type or right-sided versus left-sided tumor involvement and development of caval tumor thrombi and associations between tumor thrombi, tumor type, or right- versus left-sided location and perioperative complications and mortality rate. Survival was compared between dogs with and without tumor thrombi.
RESULTS: Caval thrombi were detected in 25% of dogs, including 3 of 28 (11%) dogs with an adrenocortical tumor and 6 of 11 dogs with a pheochromocytoma. A caval tumor thrombus was detected in 6 of 17 right-sided and 4 of 20 left-sided tumors. Sensitivity and specificity of abdominal ultrasonography for detection of caval thrombi were 80 and 90%, respectively. Intraoperative and postoperative complications developed in 15 and 51% of dogs, respectively. The mortality rate was 22%. There were no significant differences in perioperative morbidity and mortality rates between dogs with and without tumor thrombi. CONCLUSIONS AND CLINICAL RELEVANCE: Caval thrombi associated with adrenal gland tumors are amenable to adrenalectomy and thrombectomy without significantly increased perioperative morbidity and mortality rates, assuming the surgeon is experienced in appropriate techniques.

Entities:  

Mesh:

Year:  2003        PMID: 12959384     DOI: 10.2460/javma.2003.223.654

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  16 in total

1.  Animal models of adrenocortical tumorigenesis.

Authors:  Felix Beuschlein; Sara Galac; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-11-11       Impact factor: 4.102

2.  C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.

Authors:  Kayla Harding; Carlos H De Mello Souza; Keijiro Shiomitsu; Elizabeth Maxwell; Judit Bertran
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

3.  Adrenocortical tumor in a cat secreting more than one type of corticosteroid.

Authors:  Simone Domit Guerios; Carlos Henrique de Melo Souza; Nicholas J Bacon
Journal:  JFMS Open Rep       Date:  2015-12-01

4.  Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).

Authors:  Margaret L Musser; Kathryn L Taikowski; Chad M Johannes; Philip J Bergman
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

5.  Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism.

Authors:  Kirsten L van Bokhorst; Hans S Kooistra; Susanne A E B Boroffka; Sara Galac
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

6.  Anaesthetic management of a unilateral adrenalectomy of an adrenocortical tumour in a dog.

Authors:  I K Wise; S Boveri
Journal:  Open Vet J       Date:  2016-04-07

7.  Treatment of aldosterone-secreting adrenocortical tumors in cats by unilateral adrenalectomy: 10 cases (2002-2012).

Authors:  A J Lo; D E Holt; D C Brown; M D Schlicksup; R J Orsher; K A Agnello
Journal:  J Vet Intern Med       Date:  2013-12-26       Impact factor: 3.333

8.  Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Authors:  C Arenas; C Melián; M D Pérez-Alenza
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

9.  Repetitive ultrasonographic assessment of adrenal size and shape changes: a clue for an asymptomatic sex hormone-secreting adenoma.

Authors:  Seunghyeon Yoon; Heejin Oui; Ju-Hwan Lee; Kyu-Yeol Son; Kyoung-Oh Cho; Jihye Choi
Journal:  J Vet Sci       Date:  2017-03-30       Impact factor: 1.672

10.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  Mark J Acierno; Scott Brown; Amanda E Coleman; Rosanne E Jepson; Mark Papich; Rebecca L Stepien; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.